Publication | Closed Access

A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development

Drug SafetyRegulatory RequirementMedicineDrug DiscoveryAdverse Drug ReactionToxicologyPharmacovigilanceRegulatory Safety SciencePharmaceutical Drug DevelopmentPharmacologyPharmacological IssueAcute Toxicity StudiesDrug Toxicity